NEW YORK (CNN/Money) -
With the markets cooling off after a torrid summer, two money managers appeared on CNNfn to suggest some stocks in the energy, retail and medical device sectors.
Stephen Leeb, president of Leeb Capital Management, likes the valuation of ConocoPhillips.
"Conoco is a very cheap integrated oil company trading at about nine times forward earnings, much cheaper than other integrated oil companies like Exxon and Chevron," he noted. "It also has better growth prospects. It's still benefiting from the merger between the two companies, Conoco and Phillips, and so I think there are synergies to come and it's just a very well-positioned oil and gas company."
Jewelry retailer Tiffany is Leeb's other selection.
| Stephen Leeb's picks
|
|
|
|
|
"If you either believe gold is in an uptrend or you believe stocks are in an uptrend, Tiffany wins. That little blue box has been around for 150 years," he said. "And it's a relatively small company. How many companies can you name that have a market cap of about $4 or $5 billion that have a 150-year-old franchise?"
Funds under Leeb's management own stakes in the companies mentioned.
Shares of ConocoPhillips (COP: down $0.15 to $56.30, Research, Estimates) are in a 52-week range of $44.03 to $57.20.
Tiffany (TIF: up $0.48 to $38.89, Research, Estimates) shares have been between $19.40 and $40.00 in the last year.
Larry Seibert, vice chairman of OAM Avatar, says additional security spending will benefit ChoicePoint
"This is an excellent quality company, very well managed. They are an information service provider to the insurance industry and to businesses and now to consumers," he said. "And they're a big play in homeland security. They should be one of the big players in the roll-out of screening for hazardous materials truck drivers in the country."
Seibert also likes Stryker for a play in the medical device sector.
| Larry Seibert's picks
|
|
|
|
|
|
"Here's a company that grows its earnings consistently at over 20 percent a year. Smaller, so it doesn't really hit the radar of a lot of investors," he noted. "They're a device manufacturer, but they're a little bit less regulated than some of the other companies in health care."
Funds under Seibert's management own stakes in the companies mentioned.
Shares of ChoicePoint (CPS: up $0.08 to $33.98, Research, Estimates) are in a 52-week range of $28.30 to $42.10.
Stryker (SYK: down $0.13 to $73.87, Research, Estimates) share have been between $54.33 and $79.25 in the last year.
|
